COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Thursday 30 September 2021
Relatively flat day - overall average up 0.2% - Altimmune continues stumble
A very modest upswing today with a gain of 0.2% overall. There were 15 gainers and 10 losers.
Altimmune continues its bad week, was another double digit loss. Alynyam was the strongest stock, gaining over 6% today.
No comments:
Post a Comment